TPV 250 (Aptivus 250 mg)
Generic Name: tipranavir
This pill with imprint "TPV 250" is Pink, Capsule-shape and has been identified as Aptivus 250 mg. It is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Aptivus is used in the treatment of hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Aptivus 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- tipranavir
- Imprint:
- TPV 250
- Strength:
- 250 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 00597-0003
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5719 | A-S Medication Solutions, LLC (repackager) |
More about Aptivus (tipranavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: protease inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
